Recent Updates
Recently added Catalysts
PRGO Positive Sentiment

Perrigo to Release Second Quarter 2025 Financial Results on August 6, 2025 Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its second quarter 2025...

Key Takeaway: Perrigo Company plc plans to release its second quarter 2025 financial results on August 6, 2025. Alongside the release, a conference call will be held at 8:30 A.M. (EST) to discuss the results, which will be accessible via webcast and phone. The call will also be available for replay shortly after the event. Perrigo continues to establish itself as a leading provider in the consumer self-care sector, utilizing a business model that supports both private label and branded products.
Price reaction · baseline $27.55 (2025-07-22 close) · hit after-hours · clean, no other PRGO news in the window
day 0 close · peak
+2.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Perrigo's ongoing commitment to providing self-care products demonstrates their leadership in the self-care market.
  • The upcoming earnings release indicates active engagement with investors and transparency about company performance.
  • Perrigo has a strong reputation for high-quality health solutions over a century of experience.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+26%
120-day peak, hindsight
Typical move
1.3%
average across 3 past catalysts
Lead asset
Norgestrel
Phase 3 · Contraception

Full Press Release Details

DUBLIN , July 23, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO ), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its second quarter 2025 financial results on Wednesday, August 6 th , 2025, and host a conference call beginning at 8:30 A.M. (EST) .
The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184, International 646-357-8785, and reference ID # 45051. A taped replay of the call will be available beginning at approximately 12:00 P.M. (EST) Wednesday , August 6, until midnight Wednesday, August 13, 2025 . To listen to the replay, dial 888-660-6345, International 646-517-4150, and use access code 45051#.
Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe . As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill ® , Mederma ® , Compeed ® , EllaOne ® , and Jungle Formula ® .
For more information, visit www.perrigo.com .
Forward-Looking Statements
This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings , for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024 .
Perrigo Contact

Frequently Asked Questions

When will Perrigo release its Q2 2025 financial results?

Perrigo will announce its Q2 2025 financial results on August 6, 2025.

How can I participate in the earnings conference call?

You can join the call via webcast or by phone at 800-836-8184, using ID # 45051.

Will the earnings call be available for replay?

Yes, a replay will be accessible from August 6, at noon until August 13, midnight.

What is Perrigo's business focus?

Perrigo specializes in self-care products, offering OTC solutions without prescriptions.

What brands are owned by Perrigo?

Perrigo's brands include Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.

Last updated: Jul 23, 2025